About the group
Drug use in older populations is characterized by multimorbidity, polypharmacy and increased vulnerability to adverse drug effects. While medications can provide substantial benefits, treatment decisions are often complex, and the balance between benefits and harms may be uncertain.
The research group studies patterns, quality and outcomes of medication use in older people across care settings. A central focus is to strengthen the evidence base for drug treatment in populations that are often underrepresented in clinical trials, where knowledge derived from younger and healthier individuals may not be directly applicable.
Our overall aim is to improve the safety, quality and individualization of pharmacological treatment in older patients, and to support more person-centered care.
Projects
Here is an overview of our current projects:
- Potentially inappropriate drug use in patients assessed for cognitive symptoms in memory clinics in Norway
- The COOP II study:
Drug use and oral health in older people admitted to Oslo MipAC unit – an observational study - The COOP II study:
Optimization of drug use in patients admitted to Oslo MipAC unit – a randomized, controlled trial - BE-SAFE:
Implementing a patientcentred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care - Personalized pharmacological treatment in older adults with increased risk of falls – a pilot study
